BFRIW (STOCKS)
Biofrontera Inc. Warrants
$0.050100
-0.013300 (-20.98%)
Prev close: $0.063400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Hermann Lübbert, PhD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 93
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $37.16M |
| Benefits Costs and Expenses | $54.71M |
| Costs And Expenses | $54.78M |
| Nonoperating Income/Loss | $69.00K |
| Operating Expenses | $54.78M |
| Research and Development | $3.72M |
| Other Operating Expenses | $46.83M |
| Operating Income/Loss | -$17.62M |
| Income/Loss Before Equity Method Investments | -$17.55M |
| Income/Loss From Continuing Operations After Tax | -$17.57M |
| Income/Loss From Continuing Operations Before Tax | -$17.55M |
| Income/Loss From Equity Method Investments | $1.00K |
| Income Tax Expense/Benefit | $22.00K |
| Net Income/Loss | -$17.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.50 |
| Diluted Earnings Per Share | -$1.50 |
| Basic Average Shares | 10,357,621 |
| Diluted Average Shares | 10,357,621 |
| Assets | $15.42M |
| Current Assets | $14.41M |
| Inventory | $4.33M |
| Other Current Assets | $10.08M |
| Noncurrent Assets | $1.00M |
| Fixed Assets | $20.00K |
| Intangible Assets | $22.00K |
| Other Non-current Assets | $960.00K |
| Liabilities | $18.00M |
| Current Liabilities | $12.55M |
| Wages | $2.97M |
| Other Current Liabilities | $9.58M |
| Noncurrent Liabilities | $5.44M |
| Equity | -$2.58M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$2.58M |
| Liabilities And Equity | $15.42M |
| Net Cash Flow From Operating Activities | -$12.00M |
| Net Cash Flow From Operating Activities, Continuing | -$12.00M |
| Net Cash Flow From Investing Activities | -$4.00K |
| Net Cash Flow From Investing Activities, Continuing | -$4.00K |
| Net Cash Flow From Financing Activities | $12.55M |
| Net Cash Flow From Financing Activities, Continuing | $12.55M |
| Net Cash Flow | $544.00K |
| Net Cash Flow, Continuing | $544.00K |
| Comprehensive Income/Loss | -$17.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.57M |
| Other Comprehensive Income/Loss | $0.00 |